Skip to main content

Advertisement

SpringerLink
Log in

Percutaneous Cryoablation for Recurrent Head and Neck Tumors

  • Clinical Investigation
  • Non-Vascular Interventions
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

Abstract

Purpose

To report techniques and results of 16 cryoablation procedures in 11 patients treated for recurrent head and neck cancer.

Methods and Materials

This retrospective study reviewed 11 consecutive patients with head and neck cancer recurrence after primary treatment by surgery and radiotherapy, treated with cryoablation between 2016 and 2020. Efficacy was measured by local control rate evaluated on MRI or/and PET. Tumor characteristics, number of cryoprobes, thermoprotective measures and complications were documented.

Results

Sixteen cryoablation procedures were performed in 11 patients with head and neck cancer recurrence after surgery or radiotherapy, deemed ineligible for classic salvage treatment. Among 11 patients, four were treated for an epidermoid carcinoma, four for an adenocarcinoma and three for other types: 1 muco-epidermoid carcinoma, 1 adenoid cystic carcinoma and 1 esthesioneuroblastoma, 10/11 patients had prior surgery, 7/11 patients had prior chemotherapy and 3/11 patients had prior radiotherapy. Median number of cryoprobes was 4, [IQR, 3–6 cryoprobes], thermoprotective measures to protect surrounding organs were required for 10/16 procedures. After cryoablation, local control rate was 45.4% at a mean follow-up of 11.7 months (range 3–34 months). Among the 16 cryoablation procedures, four resulted in complications, two were considered major complications: one septic shock on inhalation pneumopathy during extubation, requiring intensive care; and one dysphonia due to a recurrent nerve injury.

Conclusion

Cryoablation as a salvage treatment for recurrence of head and neck tumors after surgery and/or radiotherapy is an effective option, especially for patients that cannot benefit from salvage surgery.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, et al. Head and neck cancers, version 2.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2020;18:873–98.

    Article  Google Scholar 

  2. Machiels J-P, René Leemans C, Golusinski W, Grau C, Licitra L, Gregoire V. Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS–ESMO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2020;31:1462–75.

    Article  Google Scholar 

  3. Chan ATC, Grégoire V, Lefebvre J-L, Licitra L, Hui EP, Leung SF, et al. Nasopharyngeal cancer: EHNS–ESMO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23:vii83–5.

    Article  Google Scholar 

  4. Zenga J, Graboyes E, Janz T, Drake V, Rettig E, Desai S, et al. Salvage of recurrence after surgery and adjuvant therapy: a multi-institutional study. Otolaryngol Head Neck Surg. 2019;161:74–81.

    Article  Google Scholar 

  5. Dionisi F, Fiorica F, D’Angelo E, Maddalo M, Giacomelli I, Tornari E, et al. Organs at risk’s tolerance and dose limits for head and neck cancer re-irradiation: a literature review. Oral Oncol. 2019;98:35–47.

    Article  CAS  Google Scholar 

  6. Hamoir M, Schmitz S, Suarez C, Strojan P, Hutcheson KA, Rodrigo JP, et al. The current role of salvage surgery in recurrent head and neck squamous cell carcinoma. Cancers [Internet]. 2018 [cited 2021 Apr 19]; 10. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115801/

  7. Rogers SN, Semple C, Babb M, Humphris G. Quality of life considerations in head and neck cancer: United Kingdom national multidisciplinary guidelines. J Laryngol Otol. 2016;130:S49-52.

    Article  CAS  Google Scholar 

  8. Quek LHH, Lim MY, Cheo T, Teo HL, Pua U. Percutaneous management of recurrent head and neck cancer: current role and evolving principles in the multidisciplinary setting. Curr Oncol Rep. 2021;23:52.

    Article  CAS  Google Scholar 

  9. Tsoumakidou G, Buy X, Garnon J, Enescu J, Gangi A. Percutaneous thermal ablation: how to protect the surrounding organs. Tech Vasc Interv Radiol. 2011;14:170–6.

    Article  Google Scholar 

  10. Belfiore MP, Sciandra M, Romano F, Tartaglione T, Lucia GD, Volpe TD, et al. Preliminary results in unresectable head and neck cancer treated by radiofrequency and microwave ablation: feasibility, efficacy, and safety. J Vasc Interv Radiol Elsevier. 2015;26:1189–96.

    Article  Google Scholar 

  11. Owen RP, Lee JS, Silver CE, Bäck L, Beitler JJ, Rinaldo A, et al. Radiofrequency ablation in advanced head and neck cancer. Eur Arch Otorhinolaryngol. 2014;271:207–10.

    Article  Google Scholar 

  12. Brook AL, Gold MM, Miller TS, Gold T, Owen RP, Sanchez LS, et al. CT-guided radiofrequency ablation in the palliative treatment of recurrent advanced head and neck malignancies. J Vasc Interv Radiol. 2008;19:725–35.

    Article  Google Scholar 

  13. Guenette JP, Tuncali K, Himes N, Shyn PB, Lee TC. Percutaneous image-guided cryoablation of head & neck tumors for local control, preservation of functional status, and pain relief. AJR Am J Roentgenol. 2017;208:453–8.

    Article  Google Scholar 

  14. Gangi A, Cebula H, Cazzato RL, Ramamurthy N, Garnon J, Debry C, et al. “Keeping a cool head”: percutaneous imaging-guided cryo-ablation as salvage therapy for recurrent glioblastoma and head and neck tumours. Cardiovasc Intervent Radiol. 2020;43:172–5.

    Article  Google Scholar 

  15. Magalov Z, Shitzer A, Degani D. Isothermal volume contours generated in a freezing gel by embedded cryo-needles with applications to cryo-surgery. Cryobiology. 2007;55:127–37.

    Article  CAS  Google Scholar 

  16. Gangi A, Tsoumakidou G, Buy X, Quoix E. Quality improvement guidelines for bone tumour management. Cardiovasc Interv Radiol. 2010;33:706–13.

    Article  CAS  Google Scholar 

  17. Robinson D, Halperin N, Nevo Z. Two freezing cycles ensure interface sterilization by cryosurgery during bone tumor resection. Cryobiology. 2001;43:4–10.

    Article  CAS  Google Scholar 

  18. Kurup AN, Schmit GD, Morris JM, Atwell TD, Schmitz JJ, Weisbrod AJ, et al. Avoiding complications in bone and soft tissue ablation. Cardiovasc Interv Radiol. 2017;40:166–76.

    Article  Google Scholar 

  19. Kurup AN, Morris JM, Schmit GD, Atwell TD, Weisbrod AJ, Murthy NS, et al. Neuroanatomic considerations in percutaneous tumor ablation. Radiographics. 2013;33:1195–215.

    Article  Google Scholar 

  20. Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL. Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Interv Radiol août. 2017;40(8):1141–6.

    Article  CAS  Google Scholar 

  21. U.S department of health and human services. Common terminology criteria for adverse events (CTCAE), version 5.0 [Internet]. 2017 [cited 2018 Feb 20]. Available from: https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf

  22. Matoscevic K, Graf N, Pezier TF, Huber GF. Success of salvage treatment: a critical appraisal of salvage rates for different subsites of HNSCC. Otolaryngol Head Neck Surg. 2014;151:454–61.

    Article  Google Scholar 

  23. Spencer SA, Harris J, Wheeler RH, Machtay M, Schultz C, Spanos W, et al. Final report of RTOG 9610, a multi-institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck. Head Neck. 2008;30:281–8.

    Article  Google Scholar 

  24. Langer CJ, Harris J, Horwitz EM, Nicolaou N, Kies M, Curran W, et al. Phase II study of low-dose paclitaxel and cisplatin in combination with split-course concomitant twice-daily reirradiation in recurrent squamous cell carcinoma of the head and neck: results of Radiation Therapy Oncology Group Protocol 9911. J Clin Oncol. 2007;25:4800–5.

    Article  CAS  Google Scholar 

  25. Vargo JA, Ward MC, Caudell JJ, Riaz N, Dunlap NE, Isrow D, et al. A multi-institutional comparison of SBRT and IMRT for definitive reirradiation of recurrent or second primary head and neck cancer. Int J Radiat Oncol Biol Phys. 2018;100:595–605.

    Article  Google Scholar 

  26. Anand AK, Dua B, Bansal AK, Singh HM, Verma A, Kumar A. Stereotactic ablative radiotherapy (SABR) for recurrent and previously irradiated head and neck cancers. BJR Open [Internet]. 2020 [cited 2021 Apr 27]; 2. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7594905/

  27. Vermorken JB, Mesia R, Rivera F, Remenar E, Kawecki A, Rottey S, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer [Internet]. Massachusetts Medical Society; 2009 [cited 2021 Apr 28]. Available from: https://doi.org/10.1056/NEJMoa0802656

  28. Owen RP, Khan SA, Negassa A, Beitler JJ, Bello JA, Brook A, et al. Radiofrequency ablation of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 2011;137(5):493.

    Article  Google Scholar 

  29. Cazzato RL, Garnon J, Shaygi B, Tsoumakidou G, Caudrelier J, Koch G, et al. How to perform a routine cryoablation under MRI guidance. Top Magn Reson Imaging TMRI. 2018;27:33–8.

    Article  Google Scholar 

Download references

Funding

This study was not supported by any funding.

Author information

Authors and Affiliations

  1. Service d’Imagerie Interventionnelle, Hôpitaux Universitaires de Strasbourg, 1, place de l’hopital, 67000, Strasbourg, France

    Jean Schwartz, Pierre Auloge, Guillaume Koch, Joey Marie Robinson, Julien Garnon, Roberto Luigi Cazzato & Afshin Gangi

  2. School of Biomedical Engineering and Imaging Sciences, King’s College London, London, WC2R 2LS, UK

    Afshin Gangi

  3. Service d’oto-rhino-laryngologie, Hopitaux Universitaire de Strasbourg, 1, avenue Molière, 67200, Strasbourg, France

    Joffrey Perruisseau-Carrier & Christian Debry

Authors
  1. Jean Schwartz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pierre Auloge
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guillaume Koch
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Joey Marie Robinson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Julien Garnon
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roberto Luigi Cazzato
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Joffrey Perruisseau-Carrier
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Christian Debry
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Afshin Gangi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jean Schwartz.

Ethics declarations

Conflict of interest

Julien Garnon, MD, PhD: Proctor, Galil Medical Ltd. Afshin Gangi, MD, PhD: Proctor, Galil Medical Ltd. Other authors declare that they have no conflict of interest.

Ethical Approval

For this type of study formal consent is not required.

Informed Consent

Informed consent was obtained from all individual participants (or their parent) included in the study.

Consent for Publication

Consent for publication was obtained for every individual person’s data.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Schwartz, J., Auloge, P., Koch, G. et al. Percutaneous Cryoablation for Recurrent Head and Neck Tumors. Cardiovasc Intervent Radiol 45, 791–799 (2022). https://doi.org/10.1007/s00270-022-03120-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-022-03120-3

Keywords

Search

Navigation